HAUSP is required for p53 destabilization

Cell Cycle

Volumn 3, Issue 6, 2004, Pages 687-690

  Cummins, Jordan M ^a   Vogelstein, Bert ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Deubiquitination; HAUSP; p53; Somatic cell knockouts; Tumor suppression

Indexed keywords

PROTEIN MDM2; PROTEIN P53;

ENZYME SPECIFICITY; ENZYME SUBSTRATE; GENE CONTROL; GENE DISRUPTION; GENE LOCUS; GENE OVEREXPRESSION; GENETIC RECOMBINATION; GENETIC TRANSCRIPTION; HAUSP GENE; HUMAN; HUMAN CELL; PHENOTYPE; PROTEIN FUNCTION; PROTEIN STABILITY; REVIEW; TUMOR SUPPRESSOR GENE; UBIQUITINATION;

EID: 3242774545     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.3.6.924     Document Type: Review

References (19)

1. Michael D, Oren M. The p53-mdm2 module and the ubiquitin system. Seminars in Cancer Biol 2003/2; 2003; 13:49-58.
2. Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000; 408:307-10.
3. Haupt Y, Robles AI, Prives C, Rotter V. Deconstruction of p53 functions and regulation. Oncogene Nov 28; 2002; 21:8223-31.
4. Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 1992; 358:80-3.
5. Tommasino M, Accardi R, Caldeira S, Dong W, Malanchi I, Smet A, et al. The role of tp53 in cervical carcinogenesis. Hum Mutat Mar; 2003; 21:307-12.
6. Li M, Chen D, Shiloh A, Luo J, Nikolaev AY, Qin J, et al. Deubiquitination of p53 by hausp is an important pathway for p53 stabilization. Nature 2002; 416:648-53.
7. Wing SS. Deubiquitinating enzymes-the importance of driving in reverse along the ubiquitin-proteasome pathway. Int J Biochem Cell Biol 2003; 35:590-605.
8. Hu M, Li P, Li M, Li W, Yao T, Wu JW, et al. Crystal structure of a ubp-family deubiquitinating enzyme in isolation and in complex with ubiquitin aldehyde. Cell 2002; 111:1041-54.
9. Everett RD, Meredith M, Orr A, Cross A, Kathoria M, Parkinson J. A novel ubiquitin-specific protease is dynamically associated with the pml nuclear domain and binds to a herpesvirus regulatory protein. EMBO J 1997; 16:1519-30.
10. Cummins JM, Rago C, Kohli M, Kinzler KW, Lengauer C, Vogelstein B. Tumour suppression: Disruption of hausp gene stabilizes p53. Nature 2004; 428:486 (doi:10.1038/nature02501).
11. Li M, Brooks CL, Kon N, Gu W. A dynamic role of hausp in the p53-mdm2 pathway. Mol Cell 2004; 13:879-86.
12. Jackson PK, Eldridge AG. The scf ubiquitin ligase: An extended look. Mol Cell 2002; 9:923-5.
13. Harper JW, Burton JL, Solomon MJ. The anaphase-promoting complex: It's not just for mitosis any more. Genes Dev 2002; 2002; 16:2179-206.
14. Jones SN, Roe AE, Donehower LA, Bradley A. Rescue of embryonic lethality in mdm2-deficient mice by absence of p53. Nature 1995; 378:206-8.
15. Montes de Oca Luna R, Wagner DS, Lozano G. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 1995; 378:203-6.
16. Strutt D, Johnson R, Cooper K, Bray S. Asymmetric localization of frizzled and the determination of notch-dependent cell fate in the drosophila eye. Curr Biol 2002; 12:813-24.
17. Vousden KH, Lu X. Live or let die: The cell's response to p53. Nat Rev Cancer 2002; 2:594-604.
18. Kohli M, Rago C, Lengauer C, Kinzler KW, Vogelstein B. Facile methods for generating human somatic cell gene knockouts using recominant adeno-associated viruses. Nucleic Acids Res 2004; 32:e3.
19. Hirata R, Chamberlain J, Dong R, Russell DW. Targeting transgene insertion into human chromosomes by adeno-associated virus vectors. Nat Biotechnol 2002; 20:735-8.